<DOC>
	<DOCNO>NCT02426060</DOCNO>
	<brief_summary>The objective study determine effect Imrecoxib , anti-infiammatory/analgesic agent primarily inhibit COX-2 COX-1 therapeutic dos , steady-state pharmacokinetic profile hypoprothrombinemic effect warfarin healthy volunteer .</brief_summary>
	<brief_title>A Drug Drug Interaciton Study Imrecoxib Warfarin Healthy Volunteers</brief_title>
	<detailed_description>This single center open label study assess effect Imrecoxib PK Warfarin Healthy Volunteers . The goal study follow : ass PK warfarin administer alone , Imrecoxib ; assess INR warfarin administer alone , Imrecoxib ; assess effect Imrecoxib PK/PD warfarin , assess safety tolerability warfarin administer Imrecoxib .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Adult male age 18 40 year , BMI 19~24 . Subjects , opinion investigator , healthy determine medical history , physical examination , 12 Lead ECG . Willing able provide write informed consent . History hypersensitivity Imrecoxib component . History current clinically important systemic illness , include limited cardiovascular , pulmonary , hepatobiliary , renal , hematological , gastrointestinal , endocrinological , immunological , dermatological , neurological , psychiatric disease , condition may place subject increase risk determine investigator . Any condition know interfere absorption , distribution , metabolism , excretion drug . History alcohol dependent , habitual heavy user caffeinated beverage judge investigator . Have significant blood loss ( &gt; 200mL ) donate 1 unit blood plasma within 12 week prior study entry . Have positive test Screening human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCVAb ) . Have use drug substance ( include herbal supplement ) know inhibit induce cytochrome ( CYP ) P450enzymesincluding CYP3A4 , CYP2C8 CYP2C9 within 4 week prior first dose throughout study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>